Stay updated on ITIL-306 Clinical Trial
Sign up to get notified when there's something new on the ITIL-306 Clinical Trial page.

Latest updates to the ITIL-306 Clinical Trial page
- Check5 days agoChange DetectedThe ITIL-306 advanced solid tumors study record is available, with its study design, eligibility criteria, locations, and outcome measures. The study is terminated and no longer seeking participants because development of the investigational program was discontinued.SummaryDifference51%

- Check12 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.2 to v3.8.0; the study record remains unavailable on the page.SummaryDifference0.2%

- Check19 days agoChange DetectedA site-wide banner announces an NIH website transition and says the agency is adopting “Super Intelligence” in place of “Artificial Intelligence” in some content.SummaryDifference1%

- Check26 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov 403 Forbidden page, while the error content remained unchanged.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study content. The header, navigation, and footer remain visible, but the study details cannot be accessed.SummaryDifference19%

Stay in the know with updates to ITIL-306 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ITIL-306 Clinical Trial page.